Detalles de la búsqueda
1.
Long-term follow-up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma.
Br J Haematol
; 201(2): 319-325, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36625160
2.
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma.
Ann Hematol
; 102(7): 1773-1787, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171597
3.
Three-Dimensional Reconstructed Bone Marrow Matrix Culture Improves the Viability of Primary Myeloma Cells In-Vitro via a STAT3-Dependent Mechanism.
Curr Issues Mol Biol
; 43(1): 313-323, 2021 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34201211
4.
Ineffectiveness of high-dose methotrexate for prevention of CNS relapse in diffuse large B-cell lymphoma.
Am J Hematol
; 96(7): 764-771, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33811794
5.
Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma.
Int J Mol Sci
; 22(2)2021 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33477402
6.
Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorder.
Br J Haematol
; 189(1): 97-105, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068243
7.
Epstein-Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literature.
Transpl Infect Dis
; 21(1): e13010, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30298678
8.
Real-world management of small lymphocytic lymphoma as chronic lymphocytic leukaemia versus an indolent non-Hodgkin lymphoma.
Br J Haematol
; 202(2): 445-448, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37231889
9.
Correction to: REMIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (polaBR), CART therapies, and lenalidomide/rituximab (R2) based on realworld data in patients with relapsed/refractory diffuse large Bcell lymphoma.
Ann Hematol
; 102(9): 2643-2644, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432417
10.
Rituximab monotherapy following surgical resection of gastrointestinal post-transplant lymphoproliferative disorder in solid organ transplant recipients.
Clin Transplant
; 37(2): e14910, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36629389
11.
Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable Analysis.
Biol Blood Marrow Transplant
; 22(5): 941-8, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26785331
12.
The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease.
Eur J Haematol
; 97(5): 471-478, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27028202
13.
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice.
Leuk Lymphoma
; 65(5): 609-617, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235709
14.
Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia.
Exp Hematol Oncol
; 12(1): 13, 2023 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36707896
15.
Management of Marginal Zone Lymphoma: A Canadian Perspective.
Curr Oncol
; 30(2): 1745-1759, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36826096
16.
Inferior outcomes with R-CEOP for patients with diffuse large B-cell lymphoma and cardiovascular comorbidities.
Leuk Lymphoma
; 63(3): 583-590, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34672241
17.
Tumor Infiltrating Lymphocytes Predict Survival in Solid Organ Transplant Recipients With Monomorphic Post-transplant Lymphoproliferative Disorders.
Clin Lymphoma Myeloma Leuk
; 22(10): 744-752, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717340
18.
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study.
Clin Cancer Res
; 28(18): 4003-4017, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35674661
19.
Expanded antigen-experienced CD160+CD8+effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia.
J Immunother Cancer
; 9(4)2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33931471
20.
Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma.
Blood
; 112(13): 5171-9, 2008 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18787224